1.32
Precedente Chiudi:
$1.33
Aprire:
$1.33
Volume 24 ore:
1.52M
Relative Volume:
0.53
Capitalizzazione di mercato:
$93.86M
Reddito:
$391.70K
Utile/perdita netta:
$-52.34M
Rapporto P/E:
-1.76
EPS:
-0.75
Flusso di cassa netto:
$-45.92M
1 W Prestazione:
-5.04%
1M Prestazione:
-20.96%
6M Prestazione:
+343.25%
1 anno Prestazione:
+1.54%
Ovid Therapeutics Inc Stock (OVID) Company Profile
Nome
Ovid Therapeutics Inc
Settore
Industria
Telefono
212-776-4381
Indirizzo
441 NINTH AVENUE, 14TH FLOOR, NEW YORK, NY
Confronta OVID con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
OVID
Ovid Therapeutics Inc
|
1.32 | 94.58M | 391.70K | -52.34M | -45.92M | -0.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Ovid Therapeutics Inc Stock (OVID) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-09 | Iniziato | Oppenheimer | Outperform |
| 2025-08-08 | Ripresa | B. Riley Securities | Buy |
| 2024-06-18 | Downgrade | Oppenheimer | Outperform → Perform |
| 2024-04-30 | Iniziato | B. Riley Securities | Buy |
| 2024-04-29 | Iniziato | H.C. Wainwright | Buy |
| 2024-04-05 | Iniziato | Wedbush | Outperform |
| 2023-12-21 | Iniziato | BTIG Research | Buy |
| 2023-10-13 | Iniziato | Oppenheimer | Outperform |
| 2021-04-20 | Downgrade | Cantor Fitzgerald | Buy → Neutral |
| 2021-03-03 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-12-02 | Downgrade | Citigroup | Buy → Neutral |
| 2020-12-02 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2019-09-04 | Iniziato | RBC Capital Mkts | Outperform |
| 2018-04-20 | Iniziato | Ladenburg Thalmann | Buy |
Mostra tutto
Ovid Therapeutics Inc Borsa (OVID) Ultime notizie
Historical volatility pattern of Ovid Therapeutics Inc. visualizedWeekly Trend Summary & Safe Capital Investment Plans - newser.com
Published on: 2025-11-07 10:12:51 - newser.com
Ovid Therapeutics Inc expected to post a loss of 15 cents a shareEarnings Preview - TradingView
Visual trend scoring systems applied to Ovid Therapeutics Inc.Bull Run & Expert-Curated Trade Recommendations - newser.com
How Ovid Therapeutics Inc. (1OT) stock correlates with oil markets2025 Earnings Impact & Capital Protection Trading Alerts - newser.com
Long term hold vs stop loss in Ovid Therapeutics Inc.July 2025 Setups & Step-by-Step Trade Execution Guides - newser.com
Visual analytics tools that track Ovid Therapeutics Inc. performanceJuly 2025 Volume & Verified High Yield Trade Plans - newser.com
Is Ovid Therapeutics Inc. (1OT) stock protected from inflationMarket Performance Recap & Real-Time Volume Surge Alerts - newser.com
Can trapped investors hope for a rebound in Ovid Therapeutics Inc.Market Performance Summary & Fast Moving Stock Watchlists - newser.com
Combining machine learning predictions for Ovid Therapeutics Inc.Earnings Beat & Reliable Price Breakout Signals - newser.com
Regression analysis insights on Ovid Therapeutics Inc. performanceTrade Entry Summary & Daily Growth Stock Investment Tips - newser.com
Published on: 2025-11-05 21:39:18 - newser.com
Ovid Therapeutics (OVID) May Report Negative Earnings: Know the Trend Ahead of Q3 Release - MSN
Ovid Therapeutics (OVID) to Release Earnings on Tuesday - MarketBeat
Will Ovid Therapeutics Inc. stock deliver consistent dividends2025 Market Sentiment & Target Return Focused Stock Picks - fcp.pa.gov.br
Published on: 2025-11-04 05:50:05 - newser.com
Using flow based indicators on Ovid Therapeutics Inc.Trade Entry Report & Verified Swing Trading Watchlist - newser.com
What MACD trends signal for Ovid Therapeutics Inc. (1OT) stockTrade Volume Report & Free Technical Confirmation Trade Alerts - newser.com
OVID (Ovid Therapeutics) Total Payout Yield % : 0.00 (As of Nov. 02, 2025) - GuruFocus
{固定前缀} Is SAIH a good long term investmentSector Performance Drivers & Get Free Expert Trading Recommendations - earlytimes.in
Ovid Therapeutics Inc. (OVID) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Is Ovid Therapeutics Inc. stock a safe haven assetWeekly Gains Summary & Scalable Portfolio Growth Methods - newser.com
How Ovid Therapeutics Inc. (1OT) stock moves in volatile trading sessionsM&A Rumor & Reliable Entry Point Alerts - fcp.pa.gov.br
Ovid Therapeutics (OVID) Price Target Increased by 22.06% to 4.23 - MSN
Ovid Therapeutics Inc.Common Stock (Nasdaq:OVID) Stock Quote | PRN_FinancialWrapper | PR Newswire - Markets Financial Content
Ovid Therapeutics Inc Azioni (OVID) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Ovid Therapeutics Inc Azioni (OVID) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Rona Jeffrey A | CBFO |
Feb 26 '25 |
Sale |
0.56 |
3,902 |
2,185 |
67,973 |
| ALEXANDER MARGARET A. | President and COO |
Jan 27 '25 |
Buy |
0.73 |
6,810 |
4,971 |
34,935 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):